Literature DB >> 10728349

Angiogenic growth factors: potential new treatment for acute myocardial infarction?

L M Gonçalves1.   

Abstract

In models of hind-limb ischemia and progressive coronary artery occlusion, angiogenic growth factor proteins and genes expressing growth factors have been shown to induce the development of collateral vessels and remodeling of existing collaterals. The therapeutic potential of growth factors in the setting of acute myocardial infarction may be related to non-angiogenic properties of growth factors as well, and is the focus of this review.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728349     DOI: 10.1016/s0008-6363(99)00358-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  3 in total

Review 1.  Angiogenic growth factors in myocardial infarction: a critical appraisal.

Authors:  Hemalatha Thiagarajan; UmaMaheswari Thiyagamoorthy; Iswariya Shanmugham; Gunadharini Dharmalingam Nandagopal; Anbukkarasi Kaliyaperumal
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor.

Authors:  Sonya B Seif-Naraghi; Dinah Horn; Pamela J Schup-Magoffin; Karen L Christman
Journal:  Acta Biomater       Date:  2012-06-28       Impact factor: 8.947

3.  Glucose Starvation in Cardiomyocytes Enhances Exosome Secretion and Promotes Angiogenesis in Endothelial Cells.

Authors:  Nahuel A Garcia; Imelda Ontoria-Oviedo; Hernán González-King; Antonio Diez-Juan; Pilar Sepúlveda
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.